Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 26.19%. A quarter ago, it was expected that this company would post a loss of $0.60 per share when it actually produced a loss of $0.45, delivering a surprise of 25%.Over the last four quarters, the company has s ...